Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 30, 2024
Background
Glioma
is
the
predominant
malignant
brain
tumor
that
lacks
effective
treatment
options
due
to
its
shielding
by
blood-brain
barrier
(BBB).
Astrocytes
play
a
role
in
development
of
glioma,
yet
diverse
cellular
composition
astrocytoma
has
not
been
thoroughly
researched.
Methods
We
examined
internal
diversity
seven
distinct
subgroups
through
single-cell
RNA
sequencing
(scRNA-seq),
pinpointed
crucial
using
CytoTRACE,
monocle2
pseudotime
analysis,
and
slingshot
employed
various
techniques
identify
critical
subgroups,
delved
into
communication
analysis.
Then,
we
combined
clinical
information
GBM
patients
used
bulk
(bulk
RNA-seq)
analyze
prognostic
impact
relevant
molecules
on
patients,
performed
vitro
experiments
for
validation.
Results
The
analysis
current
study
revealed
C0
IGFBP7+
cells
were
noteworthy
subpopulation
astrocytoma,
influencing
differentiation
progression
astrocytoma.
A
predictive
model
was
developed
categorize
high-
low-scoring
groups
based
IGFBP7
Risk
Score
(IGRS),
with
survival
revealing
poorer
prognosis
high-IGRS
group.
Analysis
immune
cell
infiltration,
identification
genes
differential
expression,
enrichment
analyses,
assessment
copy
number
variations,
evaluation
drug
susceptibility
conducted,
all
which
highlighted
their
significant
influence
Conclusion
This
research
enhances
comprehension
delves
factors
impacting
offers
fresh
perspectives
treating
glioma.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 29, 2024
Ovarian
carcinoma
(OC)
is
a
prevalent
gynecological
malignancy
associated
with
high
recurrence
rates
and
mortality,
often
diagnosed
at
advanced
stages.
Despite
advances
in
immunotherapy,
immune
exhaustion
remains
significant
challenge
achieving
optimal
tumor
control.
However,
the
exploration
of
intratumoral
heterogeneity
malignant
epithelial
cells
ovarian
cancer
microenvironment
still
limited,
hindering
our
comprehensive
understanding
disease.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 30, 2024
The
aim
of
this
research
was
to
gain
a
thorough
understanding
the
processes
involved
in
cell
communication
and
discover
potential
indicators
for
treating
multiple
myeloma
(MM)
through
use
single-cell
RNA
sequencing
(scRNA-seq).
And
explored
expression
myeloma-related
subgroups
on
metal
ion-related
pathways
explore
relationship
between
MM
ions.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
Cervical
cancer
is
the
fourth
most
common
in
women
globally,
and
main
cause
of
disease
has
been
found
to
be
ongoing
HPV
infection.
remains
primary
cancer-related
death
despite
major
improvements
screening
treatment
approaches,
especially
low-
middle-income
nations.
Therefore,
it
crucial
investigate
tumor
microenvironment
advanced
cervical
order
identify
possible
targets.
In
better
understand
malignant
epithelial
cells
(EPCs),
this
study
used
bulk
RNA-seq
data
from
UCSC
conjunction
with
single-cell
RNA
sequencing
ArrayExpress
database.
After
putting
quality
control
procedures
into
place,
cell
type
identification
clustering
analysis
using
Seurat
software
were
carried
out.
To
clarify
functional
pathways,
enrichment
differential
gene
expression
The
CIBERSORT
ESTIMATE
R
packages
evaluate
immune
characteristics,
univariate
multivariate
Cox
regression
analyses
extract
prognostic
features.
Furthermore,
assessments
drug
sensitivity
Eight
types
identified,
EPCs
showing
high
proliferative
stemness
Five
EPC
subpopulations
defined,
C1
NNMT+
CAEPCs
driving
differentiation.
A
NNMT
Risk
Score
(NCRS)
model
was
developed,
revealing
a
correlation
between
elevated
NCRS
scores
adverse
patient
outcomes
characterized
by
evasion.
vitro
experiments
validated
that
PLOD2
significantly
enhances
proliferation,
migration,
invasion
cells.
This
investigation
delineated
eight
five
cancer,
establishing
as
therapeutic
target.
demonstrated
its
capability,
indicating
higher
are
associated
poorer
clinical
outcomes.
validation
highlights
potential,
underscoring
critical
need
for
integrating
immunotherapy
targeted
strategies
enhance
diagnostic
approaches
cancer.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 17, 2025
High-grade
serous
ovarian
cancer
(HGSOC),
the
predominant
subtype
of
epithelial
cancer,
is
frequently
diagnosed
at
an
advanced
stage
due
to
its
nonspecific
early
symptoms.
Despite
standard
treatments,
including
cytoreductive
surgery
and
platinum-based
chemotherapy,
significant
improvements
in
survival
have
been
limited.
Understanding
molecular
mechanisms,
immune
landscape,
drug
sensitivity
HGSOC
crucial
for
developing
more
effective
personalized
therapies.
This
study
integrates
insights
from
immunology,
profiling,
analysis
identify
novel
therapeutic
targets
improve
treatment
outcomes.
Utilizing
single-cell
RNA
sequencing
(scRNA-seq),
systematically
examines
tumor
heterogeneity
microenvironment,
focusing
on
biomarkers
influencing
response
activity,
aiming
enhance
patient
outcomes
quality
life.
scRNA-seq
data
was
obtained
GEO
database
this
study.
Differential
gene
expression
analyzed
using
ontology
set
enrichment
methods.
InferCNV
identified
malignant
cells,
while
Monocle,
Cytotrace,
Slingshot
software
inferred
differentiation
trajectories.
The
CellChat
package
predicted
cellular
communication
between
cell
subtypes
other
pySCENIC
utilized
transcription
factor
regulatory
networks
within
subtypes.
Finally,
results
were
validated
through
functional
experiments,
a
prognostic
model
developed
assess
prognosis,
infiltration,
across
various
risk
groups.
investigated
scRNA-seq,
their
interactions
microenvironment.
We
confirmed
key
role
C2
IGF2+
HGSOC,
which
significantly
associated
with
poor
prognosis
high
levels
chromosomal
copy
number
variations.
located
terminal
tumor,
displaying
higher
degree
malignancy
close
association
IIIC
tissue
types.
also
metabolic
pathways,
such
as
glycolysis
riboflavin
metabolism,
well
programmed
death
processes.
highlighted
complex
fibroblasts
MK
signaling
pathway,
may
be
closely
related
tumor-associated
progression.
Elevated
PRRX1
connected
impact
disease
progression
by
modulating
transcription.
A
based
demonstrated
adverse
outcomes,
emphasizing
importance
infiltration
clinical
intervention
strategies.
oncology,
immunotherapy,
reveal
mechanisms
driving
resistance.
subtype,
linked
offers
promising
target
future
Emphasizing
sensitivity,
research
highlights
strategies
life
patients.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 20, 2025
Melanoma
is
an
aggressive
type
of
skin
cancer
that
arises
from
melanocytes,
the
cells
responsible
for
producing
pigment.
In
contrast
to
non-melanoma
cancers
like
basal
cell
carcinoma
and
squamous
carcinoma,
melanoma
more
invasive.
was
distinguished
by
its
rapid
progression,
high
metastatic
potential,
significant
resistance
conventional
therapies.
Although
it
accounted
a
small
proportion
cases,
accounts
majority
deaths
caused
due
ability
invade
deep
tissues,
adapt
diverse
microenvironments,
evade
immune
responses.
These
unique
features
highlighted
challenges
treating
underscored
importance
advanced
tools,
such
as
single-cell
sequencing,
unravel
biology
develop
personalized
therapeutic
strategies.
Thus,
we
conducted
analysis
cellular
composition
within
tumor
tissues
further
subdivided
into
subpopulations.
Through
analyzing
metabolic
pathways,
stemness
genes,
transcription
factors
(TFs)
among
in
different
phases
(G1,
G2/M,
S)
well
between
primary
foci
cells,
investigated
specific
mechanisms
underlying
metastasis.
We
also
revisited
temporal
trajectories
subpopulations,
identifying
core
subpopulation
C0
SOD3
+
cells.
Our
findings
revealed
close
relationship
pivotal
oxidative
pathways
tissues.
Additionally,
analyzed
prognostically
relevant
differentially
expressed
genes
(DEGs)
built
predictive
model
associated
with
outcomes.
selected
gene
IGF1
highest
coefficient
(coef)
value
analysis,
experimentally
validated
essential
function
proliferation
invasive
metastasis
melanoma.
infiltration
discovered
critical
roles
played
M1/M2
macrophages
progression
evasion.
Furthermore,
development
malignant
were
closely
various
forms
programmed
death
(PCD),
including
apoptosis,
autophagic
death,
ferroptosis,
pyroptosis.
often
resisted
mechanisms,
maintaining
their
growth
inhibiting
apoptosis
evading
death.
Meanwhile,
induction
ferroptosis
pyroptosis
thought
trigger
responses
helped
suppress
dissemination.
A
deeper
understanding
PCD
provided
foundation
developing
novel
targeted
therapies,
potential
enhance
treatment
efficacy.
contributed
prognostic
models
shed
light
on
research
directions
concerning
targets.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 28, 2025
Background
Osteosarcoma
(OS)
is
one
of
the
most
common
primary
malignant
bone
tumors,
primarily
originating
from
mesenchymal
tissue.
It
notorious
for
its
high
invasiveness,
disability
rate,
mortality
and
poor
prognosis.
In
metastatic
destruction
can
promote
cancer
progression,
which
closely
related
to
osteoclast
activation
imbalance
between
osteoblasts
osteoclasts.
A
large
number
studies
confirmed
that
osteoclasts
are
an
important
part
OS,
play
active
role
in
destroying
homeostasis
promoting
progress
OS.
Therefore,
we
conducted
a
detailed
study
at
single
cell
level,
aiming
find
new
OS
therapeutic
targets
prevent
tumor
progression
local
spread.
Methods
We
analyzed
single-cell
sequencing
data
patients
usedMonocle2,
Cytotrace,
Slingshot
software
analyze
pseudo-sequential
trajectory
during
progression.
CellChat
was
used
reveal
communication
cells.
PySCENIC
identify
transcription
factors
Finally,
further
demonstrated
results
by
RT-qPCR
analysis,
CCK-8
assay,
wound
healing
Transwell
etc.
Results
Through
analysis
identified
highly
specific
subgroup,
C2MKI67+
Osteoclast.
The
key
signaling
pathway
APP
top
1
factor
PPARG
this
subgroup
played
essential
roles
proliferation
differentiation.
Given
pivotal
speculated
these
pathways
could
emerge
as
novel
targets,
offering
innovative
strategies
treatment.
Conclusion
This
enhanced
our
understanding
through
scRNA-seq.
Furthermore,
discovered
amplifies
proliferation,
resulting
excessive
resorption
degradation
matrix,
thereby
creating
favorable
environment
growth.
By
innovatively
targeting
PPARG,
it
affected
thus
progression;
work
offered
insights
directions
clinical
treatment
patients.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 24, 2025
Osteosarcoma,
an
aggressive
bone
malignancy
predominantly
affecting
children
and
adolescents,
presents
significant
therapeutic
challenges
with
a
5-year
survival
rate
below
30%
in
metastatic
cases.
T-cell
exhaustion,
characterized
by
the
overexpression
of
immune
checkpoint
molecules,
contributes
to
osteosarcoma
progression
evasion.
Although
targeting
these
inhibitory
pathways
has
shown
potential
restoring
activity,
molecular
regulators
depletion
are
poorly
understood.
This
study
employed
comprehensive
bioinformatics
analyses
on
samples
from
TARGET
database,
combined
normal
tissue
data
GTEx
identify
exhaustion-associated
genes
their
co-expressed
long
non-coding
RNAs
(lncRNAs).
Gene
ontology
KEGG
pathway
were
used
elucidate
immune-related
enrichments.
A
six-lncRNA
prognostic
model
was
established
using
LASSO
regression
validated
separate
cohorts.
Functional
assays
evaluated
impact
lncRNA
AL031775.1
cell
behavior
function.
Twenty-four
key
exhaustion-related
identified
significantly
enriched
pathways,
indicating
importance
microenvironment.
The
constructed
stratified
patients
prognosis,
showing
robust
predictive
performance
across
Among
six
lncRNAs,
is
notably
downregulated
promotes
proliferation,
migration,
invasion
while
contributing
exhaustion.
In
T
cells,
downregulation
impairs
antitumor
immunity,
upregulates
molecules
LAG3,
PD1,
CTLA4,
diminishes
cytotoxic
activity
against
tumor
cells.
identifies
novel
highlights
managing
enhancing
immunity
counteracting
progression.
Targeting
represents
promising
approach
improve
immunotherapy
efficacy
osteosarcoma.
These
findings
provide
critical
insights
into
regulation
exhaustion
suggest
new
avenue
for
intervention.